Welcome to our dedicated page for Milestone Scient SEC filings (Ticker: MLSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering how Milestone Scientific turns its patented computer-controlled injection technology into revenue? Start your research here. Investors who follow FDA milestones, cash runway, or royalty streams often begin with the Milestone Scientific annual report 10-K simplified and the Milestone Scientific quarterly earnings report 10-Q filing. Stock Titan’s AI instantly extracts critical details—device approval timelines, R&D spend, and global distribution stats—so you can focus on decisions, not page counts.
Need real-time alerts? Our platform streams every Milestone Scientific Form 4 insider transactions real-time, letting you track executive buys and sells as they hit EDGAR. You’ll also find the full archive of Milestone Scientific insider trading Form 4 transactions, Milestone Scientific proxy statement executive compensation, and each Milestone Scientific 8-K material events explained in plain English. AI-powered summaries highlight why a clinical-study update or distribution agreement matters, putting complex language into context for busy professionals.
Whether you’re comparing segment revenue trends, monitoring dilution risk, or simply understanding Milestone Scientific SEC documents with AI, Stock Titan offers complete coverage. Dive into Milestone Scientific earnings report filing analysis, export tables, or set custom alerts—everything you need from a single dashboard. No more hunting across multiple sites; all MLSS filings are organized, searchable, and updated the moment they post.
BP4 S.r.l., listed as a Director and 10% Owner, reported insider sales of common stock in MILESTONE SCIENTIFIC INC. (MLSS).
The filing shows two sales: 10,000 shares sold on
The form is signed by /s/ Dr. Pedro Palau, Liquidator on
BP4 S.r.l., a director-level reporting person, reported the sale of a total of 19,210 shares of MILESTONE SCIENTIFIC INC. (MLSS) on
BP4 S.r.l., listed as a director of Milestone Scientific Inc. (MLSS), reported a sale of 10,000 shares of the issuer's common stock on 09/11/2025 at a price of $0.594 per share. After the transaction the filing indicates beneficial ownership of 9,256,972 shares, held indirectly. The Form 4 was signed by Dr. Pedro Palau, Liquidator and filed on 09/15/2025. The filing shows a single non-derivative disposition and does not disclose any derivative transactions or a Rule 10b5-1 plan.
Form 144 notice filed regarding proposed sale of 400,000 shares of Milestone Scientific, Inc. common stock, with an aggregate market value of $236,000, scheduled approximately for 09/10/2025 on the NYSE. The filing lists 78,559,147 shares outstanding for the class. The securities to be sold were originally acquired in a private placement on 05/14/2014 (2,000,000 shares) from Milestone Scientific, paid in cash. The form also reports a recent sale by BP4 Srl of 375,485 shares on 06/02/2025 for $301,082. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Milestone Scientific (NYSE:MLSS) filed a routine Form 4 reporting two small open-market sales by 10 % owner BP4 S.r.l. The insider sold 10,056 shares on 06/16/2025 at $0.8951 and 1,693 shares on 06/18/2025 at $0.88, totaling 11,749 shares (≈ $10.5 K).
Following the transactions, BP4 S.r.l.’s beneficial ownership declined by less than 0.2 % to 9,447,183 common shares. No derivative trades or additional material changes were disclosed.
FAQ
What is the current stock price of Milestone Scient (MLSS)?
What is the market cap of Milestone Scient (MLSS)?
